Detalles de la búsqueda
1.
Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.
Am J Hematol
; 99(7): 1427-1430, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642007
2.
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Cancer Treat Rev
; 127: 102751, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729086
3.
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.
Eur J Cancer
; 205: 114075, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733717
4.
[Electrolyte disorders in oncological patients]. / Principaux troubles hydro-électrolytiques chez le patient de cancérologie.
Bull Cancer
; 2023 May 17.
Artículo
en Francés
| MEDLINE | ID: mdl-37208250
5.
Psychiatric Symptoms and Cognitive Disorders in Behçet's Disease: A Single-Center, Cross-Sectional Study.
J Clin Med
; 12(9)2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37176589
6.
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.
Eur J Cancer
; 193: 113313, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748398
7.
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Eur J Cancer
; 179: 28-47, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473326
8.
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitors.
Respir Med Res
; 82: 100969, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370683
9.
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
Eur J Cancer
; 160: 134-139, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34810048
10.
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer Discov
; 12(4): 958-983, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179201
11.
[Management of adverse events associated with cancer immunotherapy]. / "Prise en charge des effets indésirables de l'immunothérapie des cancers".
Rev Prat
; 71(4): 400-407, 2021 Apr.
Artículo
en Francés
| MEDLINE | ID: mdl-34161006
12.
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
Eur J Cancer
; 158: 217-224, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34627664
13.
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities.
Eur J Cancer
; 157: 383-390, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34571335
14.
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.
Aging (Albany NY)
; 13(17): 20860-20885, 2021 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34517343
15.
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.
Brain Commun
; 3(4): fcab220, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651126
16.
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control study.
Eur J Cancer
; 156: 46-59, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425404
17.
The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models.
Front Immunol
; 10: 117, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30804937
18.
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.
JAMA Oncol
; 5(9): 1310-1317, 2019 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31169866
19.
[Specific management of the most common toxicities of anti-PD1]. / Prise en charge spécifique des toxicités les plus fréquentes des anti-PD1.
Rev Prat
; 71(4): 408-410, 2021 04.
Artículo
en Francés
| MEDLINE | ID: mdl-34161007
20.
Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients.
AIDS
; 35(6): 995-997, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33821825
Resultados
1 -
20
de 20
1
Próxima >
>>